NDS Notice Board
-
September 17, 2018
NDSAC meeting of September 9, 2018
A meeting of the National Drug Scheduling Advisory Committee (NDSAC) was held on September 9, 2018 to consider the following matters:
- March 8, 2018
National Drug Schedules: Revisions to By-law No. 2
The National Association of Pharmacy Regulatory Authorities recently underwent a change in governance. Subsequent to this change in governance, small changes were required to By-law No. 2, which sets out the framework for the operation of the National Drug Schedules (NDS) program.
- March 1, 2018
National Drug Schedules: Clarification of Vaccine Scheduling
NAPRA often receives questions about the vaccine listings in the National Drug Schedules (NDS) because some vaccines are listed individually in the NDS, while others are not.
- March 8, 2018